Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: A multicenter cohort study 2024-04-06
  2. Examining the diagnostic value of the mnemonic discrimination task for classification of cognitive status and amyloid-beta burden 2023-11-07
  3. Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 2023-07-15

Studies

6 studies carry this tag.

Date range

2009 to 2024

Top journals

  • Alzheimer's research & therapy 2
  • Clinica chimica acta; international journal of clinical chemistry 1
  • Journal of Alzheimer's disease : JAD 1
  • Journal of neurology 1
  • Neuropsychologia 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: A multicenter cohort study

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Clinica chimica acta; international journal of clinical chemistry 2024-04-06 Biomarkers

    Our results confirmed the diagnostic performance of individual plasma biomarkers Aβ42/Aβ40, p-tau181, NfL, and GFAP in Chinese dementia patients and noted that a combination of these biomarkers may be more accurate in identifying FTD/PSP patients and distinguishing AD from non-AD dementia.

  2. Examining the diagnostic value of the mnemonic discrimination task for classification of cognitive status and amyloid-beta burden

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neuropsychologia 2023-11-07 Cognitive tests and assessment

    Alzheimer's disease (AD) is the most common type of dementia, characterized by early memory impairments and gradual worsening of daily functions.

  3. Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Alzheimer's research & therapy 2023-07-15 Biomarkers

    Recent large scale CSF proteomic studies revealed several new AD candidate biomarkers related to metabolic pathways.

  4. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of Alzheimer's disease : JAD 2016-01-01 Biomarkers

    We have shown that at the prodromal stage the DLB patients had no pathological profile.

  5. Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's research & therapy 2015-12-18 Biomarkers

    For the CSF-based definition of preclinical AD, if a high specificity is required, our data support the use of Aβ42/ttau rather than using Aβ42 in isolation.

  6. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of neurology 2009-05-06 Biomarkers

    The clinical diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD) is difficult, and reliable markers are highly desired.

All topic tags with their study counts